Brief: Servier And Black Diamond Therapeutics Announce Global Licensing Agreement For BDTX-4933, A Targeted Oncology Therapy
19/03/2025 11:09
March 19 (Reuters) - Black Diamond Therapeutics Inc BDTX.O: SERVIER AND BLACK DIAMOND THERAPEUTICS ANNOUNCE GLOBAL LICENSING AGREEMENT FOR BDTX-4933, A TARGETED ONCOLOGY THERAPY BLACK DIAMOND THERAPEUTICS - TO RECEIVE $70 MILLION UPFRONT, UP TO $710 MILLION IN MILESTONES Source text: ID:nGNX5KLFVG Further company coverage: BDTX.O ((Reuters.Briefs@thomsonreuters.com))